SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is facing intense volatility following an earnings report that, while beating headline expectations, raised significant concerns about long-term growth and margin pressures in key markets like China. The community is sharply divided, with some investors eyeing historical value levels as a generational buying opportunity while many others criticize management's strategy and are rotating into competitors like Hoka and On.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is experiencing significant volatility as market participants debate its long-term competitive position following the announcement of a new stablecoin consortium by major payment networks, while the community remains divided over whether to capitalize on the recent price decline or wait for further technical support levels.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is trending as investors aggressively position around the semiconductor memory supercycle, catalyzed by strong earnings from major industry players and anticipation surrounding the upcoming U.S. listing of key holdings like SK Hynix. The community is actively discussing the role of memory as a critical bottleneck for AI infrastructure, with intense debate occurring over the cyclical nature of these stocks versus a potential long-term structural re-rating.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as investors digest a strategic data center power agreement for up to 380MW, which is being viewed as a key move toward converting their large proposal pipeline into commercial execution. The community is actively debating the deal's structure, specifically the impact of warrant-based incentives versus the need for non-dilutive capital, while balancing enthusiasm for the company's entry into the AI infrastructure power space against its historical challenges with profitability and dilution.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is seeing explosive momentum and intense social media discussion as a result of its pivot toward high-growth AI data center infrastructure and optical interconnects. Community sentiment is sharply divided, with bulls pointing to multi-year technical breakout structures and strategic product ramps as evidence of a long-term rerating, while bears are aggressively calling for a correction due to the stock's parabolic valuation and concerns over institutional liquidity.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is gaining momentum as investors anticipate an upcoming Phase 3 clinical trial initiation for its lung cancer program, which serves as a major value driver alongside its late-stage prostate cancer pipeline. The community is actively discussing the stock's significant undervaluation relative to its multi-indication market potential and potential for institutional re-rating, with many focusing on the strategic hiring of commercial leadership as a sign of confidence in imminent clinical milestones.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Power and Energy, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Power and Energy segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925, and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillar is trending as traders closely monitor recent reports that Michael Burry has initiated short positions against the company, sparking debate over whether this reflects a valid macro-bearish call on industrial cyclicals or a contrarian bet against AI-driven infrastructure demand. The stock remains a focal point for the community as they weigh institutional selling against the company's strong trend as a proxy for the ongoing global capex and data center buildout cycle.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently trending due to a significant five-fold expansion of its AI infrastructure partnership with Brookfield, which has grown from $5 billion to $25 billion. The community is actively debating the stock's valuation and volatility, with many traders focused on the company's critical role in solving the power availability bottleneck for AI data centers while others discuss potential short-term price adjustments following index rebalancing.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is trending as investors focus on its critical role as a data bridge for institutional finance and real-world asset tokenization, with community discussion centering on its long-term utility against potential regulatory shifts. Many market participants are actively debating whether current price levels represent a generational buying opportunity or a period of prolonged stagnation as the network prepares for wider adoption in the financial sector.

RoboStrategy, Inc. is a non-diversified, closed-end management investment company, which engages in investing in equity and equity-linked securities of private and public companies operating in the fields of robotics and embodied artificial intelligence. The company was founded on May 23, 2025 and is headquartered in San Juan, Puerto Rico.

RoboStrategy Inc

RoboStrategy, Inc.

RoboStrategy is experiencing significant volatility and trading interest as investors react to its unique exposure to pre-IPO humanoid robotics firms like Figure AI. The stock is currently being driven by sector-wide momentum in physical AI, with active community discussions debating its valuation versus net asset value while speculating on its potential for outsized long-term gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026

Equity

Biopharma M&A has surged to $106 billion across 201 deals through early June 2026, putting the sector on track for its strongest full-year total since the 2019 pre-pandemic peak, CNBC reported.

Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600

Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 PR Newswire NEW YORK, May 7, 2026 NEW...

Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics

The headline numbers for Apellis Pharmaceuticals (APLS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates

Apellis Pharmaceuticals (APLS) delivered earnings and revenue surprises of +139.30% and +33.65%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Apellis Pharmaceuticals (NASDAQ:APLS) Reaches New 52-Week High - Here's What Happened

Apellis Pharmaceuticals (NASDAQ:APLS) Sets New 12-Month High - What's Next...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Recommendation of "Hold" from Analysts

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) have been assigned an average recommendation of "Hold" from the twenty-three ratings firms that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, eighteen have...

Top 3 Health Care Stocks That May Collapse This Month

Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86...

Pictet Asset Management Holding SA Has $9.84 Million Stock Holdings in Apellis Pharmaceuticals, Inc. $APLS

Pictet Asset Management Holding SA grew its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 7.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 390,884 shares of the company's stock after acquiring an...

UBS Group AG Boosts Stake in Apellis Pharmaceuticals, Inc. $APLS

UBS Group AG raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 22.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,186,222 shares of the company's stock after purchasing an additio...

Jennison Associates LLC Reduces Holdings in Apellis Pharmaceuticals, Inc. $APLS

Jennison Associates LLC cut its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 65.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,504,299 shares of the company's stock after selling 2,843...

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$41.05
Prev Close	$41.06
Open	$41.05
Dividend Yield	0.00%
50-Day Moving Average	$35.35
Beta	1.25
Avg. Volume	5.78M
PE Ratio	41.01

52-Week High	$41.14
52-Week Low	$16.61
Market Capitalization	$5.25B
EPS (Annual)	$0.1724
Price to Book	12.65
Revenue Per Employee	$1.36M

Feed

News

Sentiment

Earnings

Fundamentals

Info

APLSApellis Pharmaceuticals Inc

Latest APLS News